[Gly14]‐Humanin improved the learning and memory impairment induced by scopolamine in vivo
- 1 December 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 134 (8) , 1597-1599
- https://doi.org/10.1038/sj.bjp.0704429
Abstract
Humanin is a very recently discovered 24 amino acid linear polypeptide, which protects against cell death induced by either familial Alzheimer's disease mutant of amyloid precursor protein, presenilin-1 or presenilin-2 in vitro. However, it has remained uncertain whether humanin is a useful drug for the animal model of learning and memory deficit. In this study, we evaluated the effects of [Gly(14)]-humanin, a more potent humanin analogue, on the scopolamine HBr (1 mg kg(-1) s.c.)-induced impairment of spontaneous alternation behaviour in the Y-maze, an index of short-term memory in mice. [Gly(14)]-Humanin (1000 pmol 5 microl(-1) i.c.v.) reversed the impairment without affecting the number of arm entries. These results suggest that (I) [Gly(14)]-humanin is a beneficial drug for the impairment of learning and memory and (II) it modulates the learning and memory function mediated via cholinergic systems in mice.Keywords
This publication has 12 references indexed in Scilit:
- A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and AβProceedings of the National Academy of Sciences, 2001
- Mechanisms of Neuroprotection by a Novel Rescue Factor Humanin from Swedish Mutant Amyloid Precursor ProteinBiochemical and Biophysical Research Communications, 2001
- Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in miceNeuropharmacology, 2000
- Effects of endomorphins-1 and -2, endogenous μ-opioid receptor agonists, on spontaneous alternation performance in miceEuropean Journal of Pharmacology, 2000
- Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in miceBritish Journal of Pharmacology, 1999
- Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous κ-opioid receptor agonistBritish Journal of Pharmacology, 1998
- SA4503, a novel cognitive enhancer with σ1 receptor agonist properties, facilitates NMDA receptor-dependent learning in miceEuropean Journal of Pharmacology, 1997
- Cholinergic Drug Studies in Dementia and DepressionPublished by Springer Nature ,1990
- Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist ?-carbolinesPsychopharmacology, 1988
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982